Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FACTSET RESEARCH SYSTEMS INCFDS · Entity 3493 | Principal Accounting Officer | July 11, 2019 | July 12, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FACTSET RESEARCH SYSTEMS INC
Report date July 11, 2019 · Filed July 12, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 262 |
Ending reported balance
After 2019-07-11 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-07-11 · Exercise / conversion · Acquired 502 · Balance 735 F1: Includes 29 shares acquired through the FactSet Research Systems Inc. Employee Stock Purchase Plan. Row 2 · 2019-07-11 · Sale · Disposed 473 · Balance 262 F2: Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 473, the per share sales prices ranged from $294.10 to $294.21. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold in each separate price within the range set forth in this footnote to this Form 4. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $162.96 · Expires 2027-05-01 | Direct | 1,420 |
Reported balance
After 2019-07-11 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-07-11 · Exercise / conversion · Disposed 473 · Balance 1,420 F3: Options were granted on May 1, 2017 and vest 20% annually on the anniversary date of the grant and are fully vested after five years. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 29 shares acquired through the FactSet Research Systems Inc. Employee Stock Purchase Plan.
F2: Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 473, the per share sales prices ranged from $294.10 to $294.21. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold in each separate price within the range set forth in this footnote to this Form 4.
F3: Options were granted on May 1, 2017 and vest 20% annually on the anniversary date of the grant and are fully vested after five years.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 11, 2019 Filed Jul 12, 2019 20:02 UTC | FACTSET RESEARCH SYSTEMS INC FDS · Entity 3493 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 473 | $0.00 Strike: $162.96 | $0.00 |
DisclosureSEC source: 0001437749-19-013911 · rdgdoc.xml · derivative · entry 3 Daly Brian G · CIK 0001765793 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,420 Underlying: Common Stock · 473 shares Expires 2027-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options were granted on May 1, 2017 and vest 20% annually on the anniversary date of the grant and are fully vested after five years. Read SEC document |
| July 11, 2019 Filed Jul 12, 2019 20:02 UTC | FACTSET RESEARCH SYSTEMS INC FDS · Entity 3493 | SaleCommon Stock | 473 | $294.17 | $139,142.41 |
DisclosureSEC source: 0001437749-19-013911 · rdgdoc.xml · nonDerivative · entry 2 Daly Brian G · CIK 0001765793 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262 F2 · price: Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 473, the per share sales prices ranged from $294.10 to $294.21. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold in each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| July 11, 2019 Filed Jul 12, 2019 20:02 UTC | FACTSET RESEARCH SYSTEMS INC FDS · Entity 3493 | Exercise / conversionCommon Stock | 502 | $162.96 | $81,805.92 |
DisclosureSEC source: 0001437749-19-013911 · rdgdoc.xml · nonDerivative · entry 1 Daly Brian G · CIK 0001765793 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Includes 29 shares acquired through the FactSet Research Systems Inc. Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.